_version_ 1784730558847254528
author Orfanoudaki, Eleni
Zacharopoulou, Eirini
Kitsou, Vassiliki
Karmiris, Konstantinos
Theodoropoulou, Angeliki
Mantzaris, Gerassimos J.
Tzouvala, Maria
Viazis, Nikos
Michopoulos, Spyridon
Zampeli, Evanthia
Michalopoulos, Georgios
Karatzas, Pantelis
Liatsos, Christos
Bamias, Giorgos
Koutroubakis, Ioannis E.
author_facet Orfanoudaki, Eleni
Zacharopoulou, Eirini
Kitsou, Vassiliki
Karmiris, Konstantinos
Theodoropoulou, Angeliki
Mantzaris, Gerassimos J.
Tzouvala, Maria
Viazis, Nikos
Michopoulos, Spyridon
Zampeli, Evanthia
Michalopoulos, Georgios
Karatzas, Pantelis
Liatsos, Christos
Bamias, Giorgos
Koutroubakis, Ioannis E.
author_sort Orfanoudaki, Eleni
collection PubMed
description
format Online
Article
Text
id pubmed-9212327
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AGA Institute. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92123272022-06-22 Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE Orfanoudaki, Eleni Zacharopoulou, Eirini Kitsou, Vassiliki Karmiris, Konstantinos Theodoropoulou, Angeliki Mantzaris, Gerassimos J. Tzouvala, Maria Viazis, Nikos Michopoulos, Spyridon Zampeli, Evanthia Michalopoulos, Georgios Karatzas, Pantelis Liatsos, Christos Bamias, Giorgos Koutroubakis, Ioannis E. Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212327/ http://dx.doi.org/10.1016/S0016-5085(22)62388-6 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle AGA Abstracts
Orfanoudaki, Eleni
Zacharopoulou, Eirini
Kitsou, Vassiliki
Karmiris, Konstantinos
Theodoropoulou, Angeliki
Mantzaris, Gerassimos J.
Tzouvala, Maria
Viazis, Nikos
Michopoulos, Spyridon
Zampeli, Evanthia
Michalopoulos, Georgios
Karatzas, Pantelis
Liatsos, Christos
Bamias, Giorgos
Koutroubakis, Ioannis E.
Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
title Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
title_full Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
title_fullStr Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
title_full_unstemmed Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
title_short Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
title_sort tu1550: real world use and adverse events of sars-cov-2 vaccination in greek patients with inflammatory bowel disease
topic AGA Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212327/
http://dx.doi.org/10.1016/S0016-5085(22)62388-6
work_keys_str_mv AT orfanoudakieleni tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT zacharopouloueirini tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT kitsouvassiliki tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT karmiriskonstantinos tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT theodoropoulouangeliki tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT mantzarisgerassimosj tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT tzouvalamaria tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT viazisnikos tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT michopoulosspyridon tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT zampelievanthia tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT michalopoulosgeorgios tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT karatzaspantelis tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT liatsoschristos tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT bamiasgiorgos tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease
AT koutroubakisioannise tu1550realworlduseandadverseeventsofsarscov2vaccinationingreekpatientswithinflammatoryboweldisease